Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Humanin Peptide, CAS 330936-69-1 Peptide for cancer research

Humanin Peptide, CAS 330936-69-1 US$291.15 Excluding tax and shipping fees In stock Description About Humanin Peptide, CAS 330936-69-1 Humanin Peptide, CAS 330936-69-1 (Uniprot: Q8IVG9) is a cytoprotective peptide for cancer-targeting research. The Humanin Pep

Humanin Peptide, CAS 330936-69-1

US$291.15

Excluding tax and shipping fees

In stock

Description

About Humanin Peptide, CAS 330936-69-1

Humanin Peptide, CAS 330936-69-1 (Uniprot: Q8IVG9) is a cytoprotective peptide for cancer-targeting research. The Humanin Peptide, CAS 330936-69-1 peptide, H-MAPRGFSCLLLLTSEIDLPVKRRA-OH from JPT is produced under strict quality control and quality management.

Humanin Peptide, CAS 330936-69-1 - Specifications

Peptide sequence: H-MAPRGFSCLLLLTSEIDLPVKRRA-OH

Amount: 5 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

Non-RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s Non-RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for Humanin Peptide, CAS 330936-69-1

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for Humanin Peptide, CAS 330936-69-1

Humanin Peptide-CAS 330936-69-1.pdf

Properties

Properties of Humanin Peptide, CAS 330936-69-1

5 mg

Cancer biomarker research

Cancer peptides

Freeze-dried in plastic vial

Human

Humanin

>90% (HPLC-MS)

No

Further Information to Humanin Peptide, CAS 330936-69-1

Values

H-MAPRGFSCLLLLTSEIDLPVKRRA-OH

24mer cancer peptide

Original source

Review the original record for full context and limitations.

Open jpt.com ↗
CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Which Age-Related Diseases Show Promise with Humanin Peptide Research?

Research highlights three major conditions where humanin peptide demonstrates protective effects. Alzheimer’s studies show it reduces amyloid beta toxicity and preserves memory function. Cardiovascular research reveals humanin protects heart cells during oxygen deprivation events. Type 2 diabetes models demonstrate improved insulin sensitivity and glucose metabolism. MOTS-c enhances these metabolic benefits through mitochondrial energy regulation. Recent data suggests humanin levels predict disease progression in aging populations. Peptide Works provides researchers studying these conditions with quality humanin peptide.